Literature DB >> 16705571

High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan.

Delia Boccia1, Jean-Paul Guthmann, Hilde Klovstad, Nuha Hamid, Mercedes Tatay, Iza Ciglenecki, Jacques-Yves Nizou, Elisabeth Nicand, Philippe Jean Guerin.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) causes acute onset of jaundice and a high case-fatality ratio in pregnant women. We provide a clinical description of hospitalized case patients and assess the specific impact on pregnant women during a large epidemic of HEV infection in a displaced population in Mornay camp (78,800 inhabitants), western Darfur, Sudan.
METHODS: We reviewed hospital records. A sample of 20 clinical cases underwent laboratory confirmation. These patients were tested for immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody to HEV (serum) and for amplification of the HEV genome (serum and stool). We performed a cross-sectional survey in the community to determine the attack rate and case-fatality ratio in pregnant women.
RESULTS: Over 6 months, 253 HEV cases were recorded at the hospital, of which 61 (24.1%) were in pregnant women. A total of 72 cases (39.1% of those for whom clinical records were available) had a diagnosis of hepatic encephalopathy. Of the 45 who died (case-fatality ratio, 17.8%), 19 were pregnant women (specific case-fatality ratio, 31.1%). Acute hepatitis E was confirmed in 95% (19/20) of cases sampled; 18 case-patients were positive for IgG (optical density ratio > or =3), for IgM (optical density ratio >2 ), or for both, whereas 1 was negative for IgG and IgM but positive for HEV RNA in serum. The survey identified 220 jaundiced women among the 1133 pregnant women recorded over 3 months (attack rate, 19.4%). A total of 18 deaths were recorded among these jaundiced pregnant women (specific case-fatality ratio, 8.2%).
CONCLUSIONS: This large epidemic of HEV infection illustrates the dramatic impact of this disease on pregnant women. Timely interventions and a vaccine are urgently needed to prevent mortality in this special group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705571     DOI: 10.1086/504322

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  61 in total

Review 1.  Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations.

Authors:  Eugene Lam; Amanda McCarthy; Muireann Brennan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis.

Authors:  Christopher M Howard; Thomas Handzel; Vincent R Hill; Scott P Grytdal; Curtis Blanton; Saleem Kamili; Jan Drobeniuc; Dale Hu; Eyasu Teshale
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

Review 4.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

Review 5.  Liver diseases in pregnancy: diseases not unique to pregnancy.

Authors:  Ashraf A Almashhrawi; Khulood T Ahmed; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection.

Authors:  Emily S Gurley; Amal K Halder; Peter K Streatfield; Hossain M S Sazzad; Tarique M Nurul Huda; M Jahangir Hossain; Stephen P Luby
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

7.  Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus.

Authors:  Tauseef Ahmad; Saima Nasir; Taha Hussein Musa; Saif Aldeen S AlRyalat; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

8.  Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas.

Authors:  Mélanie Caron; Mirdad Kazanji
Journal:  Virol J       Date:  2008-12-22       Impact factor: 4.099

9.  Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana.

Authors:  Andrew A Adjei; Yao Tettey; John T Aviyase; Clement Adu-Gyamfi; Samuel Obed; Julius A A Mingle; Patrick F Ayeh-Kumi; Theophilus K Adiku
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

10.  Hepatitis E epidemic, Uganda.

Authors:  Eyasu H Teshale; Christopher M Howard; Scott P Grytdal; Thomas R Handzel; Vaughn Barry; Saleem Kamili; Jan Drobeniuc; Samuel Okware; Robert Downing; Jordan W Tappero; Barnabas Bakamutumaho; Chong Gee Teo; John W Ward; Scott D Holmberg; Dale J Hu
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.